Robotic weeders are evolving quickly. Some zap their targets with lasers, hot oil or electricity, others target them wit…

Seattle-based ag robotics firm Carbon Robotics has blamed “broader economic conditions” for an undisclosed number of lay…

Eastman has launched Esmeri SK1N10, a biodegradable micropowder for skin care and SPF applications that aims to balance sustainability with consumer demand for sensorial performance. The release comes amid tightening synthetic ingredient regulations. 

The EU’s incoming citral restrictions contain staggered deadlines that could catch out some cosmetics companies. Personal care products containing the same molecule may have to exit shelves a month apart, creating compliance confusion. 

Ag robotics specialist Reservoir is opening a new site in Washington’s Yakima Valley as its on-farm community for …

58 KEY POINTS A growing number of agritech founders are returning for a second attempt after their first venture failed.…

Why it matters: Alzheimer’s has no cure, and the EU-approved antibodies lecanemab and donanemab only slow decline in selected early-stage patients with confirmed amyloid and no more than one copy of the ApoE4 gene variant, while requiring infusions and monitoring for brain swelling and bleeding. Rather than targeting amyloid deposits, Muna’s pill aims to strengthen microglia, the brain’s immune cells, through TREM2, a receptor whose impaired function raises Alzheimer’s risk.

Why it matters: With this round, Arctic is backing AT-002 and AT-003, treatments that could address gaps in the care of patients with autoimmune diseases such as uveitis, an eye inflammation that can threaten sight and whose steroid treatment increases the risk of glaucoma or cataracts. Meanwhile, its clinical-stage drugs target acne (AT-004) and dementia (AT-001), starting with HCCAA, a rare, fatal inherited disease that causes brain hemorrhages and dementia.